Abstract:Purpose: 10-Hydroxycamptothecin (HCPT) is an indole alkaloid isolated from a Chinese tree, Camptotheca acuminata, and has a wide spectrum of anticancer activity in vitro and in vivo mainly through inhibitory effects on topoisomerase I. HCPT has been shown to be more potent and less toxic than camptothecin and has recently undergone clinical trials. To determine how HCPT might be best used as an anticancer agent, preclinical studies of the pharmacokinetics, tissue distribution, metabolism and elimination of HCPT in rats were undertaken. Methods: HCPT was administered to rats by i.v. bolus injection at doses of 1, 3, and 10 mg/kg body weight. HCPT (lactone and carboxylate) and its metabolites in plasma, urine, feces, and various tissues were quantitated by reversed-phase HPLC. Pharmacokinetic parameters were then estimated. Results: Following i.v. administration at doses of 3 or 10 mg/kg, the plasma concentration-time profile for lactone HCPT could be best described by a three-compartment model, with terminal elimination half-lives of 140.4 and 428.6 min, respectively. A two-compartment model was used to fit the plasma concentration-time curve at 1 mg/kg, with a terminal elimination half-life of 30.5 min. Carboxylate HCPT had a longer half-life than the lactone form of HCPT. During the initial 6 h after dosing, urinary excretion was the major route of elimination, and fecal excretion became the major route of elimination thereafter. HCPT was widely distributed to various tissues including the enterohepatic system, kidney, and bone marrow. The lactone form of HCPT was detectable in various tissues examined up to 72 h after dosing at all the three test doses. HCPT glucuronides were present in plasma, urine, feces and various tissues. No significant toxicity was observed at doses of 1 or 3 mg/kg. Polyuria and hematuria were observed only during the initial 3 h after dosing at 10 mg/kg. Conclusions: Prolonged elimination of HCPT in vivo may have a significant impact on its therapeutic effects. HCPT is metabolized to its carboxylate form and glucuronides. Dose-dependent toxicity was observed with i.v. administration of HCPT. The results of this study should be useful in the design of future human trials with this anticancer drug.

Antitumor mechanisms of 10-hydroxycamptothecin against T 24 human urinary bladder cancer cells

Mechanism of Apoptotic Induction on T24 Cells by Honokiol and Its Synergistic Anticancer Effect in Combination with Hydroxycamptothecin

AMPK-mTOR-ULK1 axis activation-dependent autophagy promotes hydroxycamptothecin-induced apoptosis in human bladder cancer cells

Hydroxycamptothecin Induced Apoptosis in 5637 Cells Line:An In-vitro Model for High-risk Superficial Bladder Cancer

[Inhibition Effect of Topotecan on Human Myelodysplastic Syndrome Cells in Vitro and in Vivo].

Antiangiogenic potential of 10-hydroxycamptothecin

Apoptotic mechanism of pirarubicin against bladder cancer

10-Hydroxycamptothecin induces apoptosis in human neuroblastoma SMS-KCNR cells through p53, cytochrome c and caspase 3 pathways.

Preclinical pharmacology of the natural product anticancer agent 10-hydroxycamptothecin, an inhibitor of topoisomerase I

MONCPT exerts anti-cancer activities via inducing G2/M arrest and apoptosis in human bladder cancer.

Anticancer Properties of 10-Hydroxycamptothecin in A Murine Melanoma Pulmonary Metastasis Model in Vitro and in Vivo

Genistein sensitizes bladder cancer cells to HCPT treatment in vitro and in vivo via ATM/NF-κB/IKK pathway-induced apoptosis

Anticancer effects of low-dose 10-hydroxycamptothecin in human colon cancer

Effect of combined administration of hydroxycamptothecin and pirarubicin in human bladder cancer cell line 5637

Apigenin promotes apoptosis, inhibits invasion and induces cell cycle arrest of T24 human bladder cancer cells

Mechanism of bladder cancer T24 cell apoptosis induced by CDHS801 photodynamic therapy

Heptaphylline suppresses the proliferation and migration of human bladder cancer cells via induction of intrinsic apoptosis, autophagy and inhibition of -catenin signalling pathway

Effect of Camptothecin on Proliferation,Apoptosis and Telomerase Activity in HaCaT Cells

THE INHIBITORY EFFECT OF MELATONIN ON THE GROWTH OF HUMAN BLADDER CARCINOMA T24 CELL LINE

The Cytotoxic Effect,cell Cycle Perturbations and Apoptosis by Gemcitabine in Human Bladder Cancer Lines

Inhibitory Effect of Human Beta-Defensin-1 on Bladder Cancer T24 Cells and Its Mechanism